ߜ Cerebral deep central arteriovenous malformations (AVMs) are uncommon lesions associated with considerable difficulty in treatment. The authors report a series of 14 deep central AVMs treated by endovascular methods and examine the present role of endovascular treatment. This treatment used alone resulted in complete obliteration of AVMs in approximately 15% of cases and reduction in 50% to a size permitting treatment by means of radiosurgery. Reversal of previous neurological signs and symptoms occurred in 35.7% of embolized patients. Overall, nearly 80% of patients had either complete obliteration of the lesion, reduction to a size allowing radiosurgical treatment, or reversal of previous neurological deficits. There were treatment complications in 14.3% of the cases. Endovascular treatment methods may make a significant contribution to the therapy of AVMs that have a particularly poor course and are difficult to treat by other means.
In most series, these lesions account for 3% to 12% of all b rain AV M s .
2 , 3 , 5 , 1 2 Their critical location pre d i s p o s e s p atients to seve re neuro l ogical deficits, part i c u l a rly memo ry and cog n i t ive disord e rs, as a result of hemorr h age and other mechanisms of injury to surrounding brain tissue. Some evidence suggests that deep ly located AVMs may h ave a more aggre s s ive clinical course than AVMs in other l o c ations of the bra i n . 9 This suggests the importance of e a rly therapy for these lesions if neuro l ogical function is to be pre s e rve d.
Tre atment decisions on deep central AVMs are diffi c u l t not only because of uncertainty about the nat u ral history of these lesions, but also because of the lack of effe c t ive t re atment options. Early surgical ex p e rience with deep c e n t ral AVMs resulted in a high perc e n t age of poor outcomes. Although seve ral small series have suggested the feasibility of using micro s u rgical techniques in selected p atients, the best management of these lesions remains a p ro bl e m . The role of endovascular tre atment for the subset of d e ep central AVMs has not been ex a m i n e d. We rep o rt 14 cases of deep central AVMs tre ated with endova s c u l a r e m b o l i z ation, using current techniques. The purpose of this study is to eva l u ate the utility of present endova s c u l a r methods in the management of this subset of therap e u t ic a l ly difficult AV M s .
Clinical Material and Methods

Selection and History
We rev i ewed the re c o rds of 14 patients with AV M s i nvolving the thalamus, basal ganglia, and/or internal capsule who had been tre ated by endovascular methods at N ew Yo rk Unive rsity Medical Center and the Hospital of the Unive rsity of Pe n n s y l vania during the period fro m 1988 to 1992. Individuals with aneurysm malfo rm ation of the vein of Galen presenting during the neonatal peri o d we re ex cluded because these lesions differ anat o m i c a l ly and cl i n i c a l ly. 1 3 All lesions we re symptomat i c. Six of the patients had ex p e rienced an intra c ranial hemorr h age. Two had re c ove red completely from the hemorr h age and we re neuro l ogi c a l ly intact at the time of embolization. The re m a i n i n g four with a history of hemorr h age manifested static neu- 
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Deep central arteriovenous malformations of the brain: the role of endovascular treatment ro l ogical deficits without ch a n ge for at least 3 months preceding tre atment. Th ree of these had hemiparesis cont ra l at e ral to the AVM and one had seizures and stat i c m e m o ry defi c i t s .
All patients we re eva l u ated by a team consisting of a vascular neuro s u rgeon, neuro l ogist, and interve n t i o n a l n e u ro ra d i o l ogist and we re selected from a populat i o n re fe rred for possible endovascular tre atment of their AVMs. Consideration for this tre atment was based on major neuro l ogical signs and symptoms or a history of h e m o rr h age re fe rable to a deep central AVM ( Table 1) .
The eight patients in whom a magnetic re s o n a n c e (MR) image or computeri zed tomograp hy (CT) scan had ex cluded hemorr h age, had re l at ive ly acute or progre ss ive neuro l ogical deficits that had developed or wo rs e n e d in the 3 months preceding the embolization pro c e d u re. P rogre s s ive hemiparesis was the most common neuro l ogical deficit in this group, occurring in four cases. Other acute or progre s s ive neuro l ogical pro blems incl u d e d diplopia, upper-ex t remity sensory deficits and progre s s ive d eb i l i t ating headaches, progre s s ive memory deficit, and d evelopmental delay, each deficit occurring in one pat i e n t .
Fo u rteen patients (nine males and five females) underwent tre atment; the ave rage age at the time of embolization was 29.1 ye a rs. Th ree of the patients we re under 10 ye a rs of age and the remainder we re over 19 ye a rs of age. Twe l ve of the lesions we re unilat e ral with a ri g h t -t o -l e f t ratio of 1.4:1; two of the lesions we re bilat e ra l .
The AVMs ra n ged in size from 2.5 to 7 cm prior to e m b o l i z ation, and all ex c ept one we re initially too large (Ͼ 3.5 cm) for ra d i o s u rgical therapy (92.9%). The pat i e n t with the smallest (2.5 cm) AVM had ex p e rienced thre e l i fe -t h re atening hemorr h ages in less than 1 month. None of the patients had undergone prior surgical re s e c t i o n , although dra i n age of hematomas associated with elevat e d i n t ra c ranial pre s s u re had been perfo rmed on two .
E n d ovascular tre atment methods used after 1988 are s i g n i fi c a n t ly improved from those employed prior to that time because of advances in micro c atheter tech n o l ogy and d evelopment of newer embolic agents; there fo re pat i e n t s t re ated prior to 1988 we re ex cluded from eva l u at i o n . Since 1988 N-bu t y l cya n o a c ry l ate (Ava c ryl) has been our embolic agent of ch o i c e. Prior to 1988 isobu t y l cya n o a c ryl ate was the acrylic compound used for embolizat i o n . Ava c ryl not only provides permanent vessel occl u s i o n but also confe rs significant safety adva n t ages over isobut y l cya n o a c ry l at e, including more fl exibility in injection time. 1 
Surgical Procedure
Pe rcutaneous embolization pro c e d u res we re perfo rm e d using va ri abl e -s t i ffness micro c at h e t e rs wh i ch we re placed within vessels feeding the AVM nidus. Selective angi ographic ex a m i n ation was perfo rmed to ex clude bra n ch e s s u p p lying normal brain. If normal vessels we re identifi e d, the catheter was repositioned; if it was impossible to elimi n ate filling of normal bra n ches, the pedicle was not em-
Results
Surgical Treatment
E n d ovascular embolization alone or in combinat i o n with ra d i o s u rge ry was used to tre at 14 deep central AV M s i nvolving the thalamus, basal ganglia, and/or intern a l c ap s u l e. Th i rteen of the 14 (92.9%) AVMs we re initially too large to undergo ra d i o s u rge ry. Embolizaton was perfo rmed to reduce the size of the lesion, reduce ve n o u s hy p e rtension, and permit ra d i o s u rgical tre atment wh e n ever possibl e. Fo l l owing embolization, complete obl i t e rat i o n of the lesion was ach i eved in 14.3%. In nearly one-third of p atients, regression of neuro l ogical deficits occurred within 1 month fo l l owing partial embolizat i o n .
In an additional 50% of the cases, embolization re d u c e d the lesion to a size wh e re ra d i o s u rge ry was possible and all of these patient have undergone ra d i o s u rge ry.
Angioarchitecture of the Lesions
The basal perfo rating art e ries constituted the major supp ly to these lesions. The thalamoperfo rating art e ries and l e n t i c u l o s t ri ate art e ries we re the most common sources of a rt e rial supply and either or both we re invo l ved in supplying 13 of the AVMs. Supply from both thalamoperfo rat i n g and lenticulostri ate vessels was present in seven pat i e n t s . We we re able to unequivo c a l ly identify the supply fro m t h a l a m oge n i c u l ate bra n ches of the posterior cereb ral art e ries in only two cases, although ove rl ap of enlarged posterior ch o roidal vessels in this region may have masked thala m oge n i c u l ate supply in other pat i e n t s .
Th ree AVMs re c e ived perfo rating art e ry supply solely f rom the anterior portion of the circle of Willis via the l e n t i c u l o s t ri ate art e ries. Two AVMs re c e ived perfo rat i n g vessel supply from only the posterior portion of the circl e of Willis. The remaining nine lesions re c e ived supply f rom both anterior and posterior portions of the circle of Willis, re flecting the large ro s t rocaudal extent of most of the lesions (Fi g. 1) . Some contri bution from cort i c a l b ra n ches was present in four AVMs (28.6%) but in no case did these vessels constitute the major portion of supply. The deep ori gin of art e rial supply constitutes a major dif-ficulty in the surgical therapy of these lesions. Art e ri a l s u p p ly from both anterior and ve rt eb robasilar circ u l at i o n s was present in most (64.3%) of the patients. Nearly 15% of the lesions we re bilat e ra l .
A n gi ograms obtained in two patients demonstrat e d i n t ranidal aneurysms (Fi g. 2); howeve r, no feeding art e ry a n e u rysms we re identifi e d. Late-sequence angi ograp h i c films of venous dra i n age we re eva l u ated in all pat i e n t s . D e ep venous dra i n age, defined as dra i n age via either the basal vein of Rosenthal or the internal cereb ral vein to the vein of Galen and straight sinus, was present in all pat i e n t s as expected from the location of the lesion (Fi g. 3) .
A single embolization pro c e d u re was perfo rmed in s even patients and the remaining seven we re tre ated in a s t aged manner with up to four pro c e d u res. Indiv i d u a l s under the age of 19 ye a rs had embolization perfo rm e d under ge n e ral anesthesia, wh e reas local anesthesia with s e d ation was used in older patients. Final postembolization films we re compared with pre e m b o l i z ation films to e s t i m ate the perc e n t age of each AVM that had been o c cl u d e d. It was found that the nidus size of seven lesions (50%) had been reduced to less than 35 mm. All seve n p atients subsequently underwent ra d i o s u rge ry ( Table 2) . The ave rage amount of decrease in nidus size was 67.2% and ra n ged from 30% to 100%.
O n e -h u n d red percent obl i t e ration or complete cure of the lesion was ach i eved in two (14.3%) additional cases. Complete obl i t e ration was present fo l l owing a single emb o l i z ation in one case; howeve r, the patient refused fo ll ow-up angi ographic eva l u ation to confi rm continu e d o c clusion. In a second case, over 90% occlusion of the nidus was ach i eved at the time of embolization and fo ll ow-up angi ograms revealed that the lesion was completely obl i t e rat e d.
Within 1 month of the fi rst embolization, four pat i e n t s (28.6%) showed improvement of neuro l ogical defi c i t s , i n cluding partial resolution of cranial nerve palsy and opht h a l m o p a resis in one patient and of hemiparesis in thre e.
At fo l l ow-up ex a m i n ation 4 ye a rs lat e r, the residual oculomotor disturbance was corrected with strab i s mus surge ry and prisms. Improvement of previous hemipare s i s has occurred in both patients who had complete obl i t e ration of their lesions by embolization. The third pat i e n t with hemiparesis prior to embolization continues to mani fest normal strength and gait with mildly increased deep tendon re fl exes 2 ye a rs after tre atment. A fifth pat i e n t ex p e rienced resolution of upper-ex t remity sensory defi c i t s and relief of prev i o u s ly deb i l i t ating headaches within 2 weeks after the pro c e d u re. Ove rall, five (35.7%) of the p atients manifested improvement in neuro l ogical signs or symptoms fo l l owing embolization, seven (50%) we re u n ch a n ged neuro l ogi c a l ly, and two ex p e rienced intra c ranial hemorr h age 3 months and 1 ye a r, re s p e c t ive ly, fo ll owing embolization. In both of these individuals, tra nsient wo rsening of hemiparesis occurred but subsequent re t u rn to neuro l ogical baseline was ach i eve d.
Six (42.9%) of the patients had lesions too large fo r ra d i o s u rgical tre atment even after embolization; howeve r, fo l l owing only partial embolization two ex p e rienced sign i ficant resolution of neuro l ogical deficits including hemip a resis and ophthalmoplegia. Their clinical improve m e n t has persisted for 2 and 5 ye a rs, re s p e c t ive ly, without add itional therapy.
N ew-onset neuro l ogical deficits associated with emb o l i z ation occurred in two patients (14.3%). Wo rsening of p revious left-sided hemiparesis and development of h e m i s e n s o ry deficits and dysesthesia occurred in one individual. A second patient also sustained a new hemisensory deficit with dysesthesia. These findings are compat i bl e with thalamic pain syndro m e. In these last two cases, the p receding embolization pro c e d u re had invo l ved occl u s i o n of feeding pedicles ori gi n ating from the proximal posterior cereb ral art e ry on the side contra l at e ral to the defi c i t .
A mytal injection was accomplished in both cases prior to e m b o l i z ation without neuro l ogical ch a n ge. No signifi c a n t i m p rovement of the hemiparesis has oc-curred at 5-ye a r fo l l ow-up rev i ew in the fi rst patient with embolizat i o nre l ated complication; howeve r, considerable resolution of s e n s o ry symptoms occurred with only mild dy s e s t h e s i a p resent on the left side of the face and body. 
Discussion
Lesion Size Reduction
O bl i t e ration rates for AVMs in the ra n ge of 80% have been obtained with the use of ra d i o s u rge ry for small
